drugset / Trial / NCT01657266
Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of the ophthalmic solution PRO-155 in patients post phacoemulsification.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-03
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | 0.09 % | Other |
| Comparator | Nepafenac | Other / unclassified | 0.1 % | Other |